Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03032484 · ClinicalTrials.gov registry record · Phase 2
TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma
A Phase 2 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT03032484 is a Phase 2 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 25 participants.
The verdict
NCT03032484, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
Randomized phase 2 study TVB-2640 in combination with Bevacizumab versus Bevacizumab alone.
Interventions
- DRUG Bevacizumab
- DRUG TVB-2640
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-05-18 |
| Est. Completion | 2021-04-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03032484
The ClinicalTrials.gov registry entry for NCT03032484 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bevacizumab is the first listed.
NCT03032484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03032484 about?
NCT03032484 is a clinical study titled "TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma". Randomized phase 2 study TVB-2640 in combination with Bevacizumab versus Bevacizumab alone.
What is the current status of trial NCT03032484?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2017-05-18. Estimated completion is 2021-04-05.
What interventions are being tested in trial NCT03032484?
The interventions under investigation include: Bevacizumab (DRUG), TVB-2640 (DRUG).
Who is sponsoring clinical trial NCT03032484?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.